Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.
Recent studies show that patients with myotonic dystrophy (DM) have an increased risk of specific malignancies, but estimates of absolute cancer risk accounting for competing events are lacking. Using the Swedish Patient Registry, we identified 1,081 patients with an inpatient and/or outpatient diag...
Main Authors: | Shahinaz M Gadalla, Ruth M Pfeiffer, Sigurdur Y Kristinsson, Magnus Björkholm, James E Hilbert, Richard T Moxley, Ola Landgren, Mark H Greene |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3827449?pdf=render |
Similar Items
Similar Items
-
Benign tumors in myotonic dystrophy type I target disease‐related cancer sites
by: Rotana Alsaggaf, et al.
Published: (2019-08-01) -
Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries
by: Cecilia Higgs, et al.
Published: (2019-10-01) -
Congenital Myotonic Dystrophy
by: J Gordon Millichap
Published: (1987-09-01) -
Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study
by: Youjin Wang, et al.
Published: (2020-01-01) -
Two Cases of Endometrial Cancer in Twin Sisters with Myotonic Dystrophy
by: Ezra Y. Koh, et al.
Published: (2016-01-01)